Cirrus Logic (CRUS) 10-Q 4 Feb 25 2025 Q3 Quarterly report Financial data

Cover

Cover - shares	9 Months Ended
	Dec. 28, 2024	Jan. 31, 2025
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Dec. 28, 2024
Document Transition Report	false
Entity File Number	0-17795
Entity Registrant Name	CIRRUS LOGIC, INC.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	77-0024818
Entity Address, Address Line One	800 W. 6th Street
Entity Address, City or Town	Austin,
Entity Address, State or Province	TX
Entity Address, Postal Zip Code	78701
City Area Code	(512)
Local Phone Number	851-4000
Title of 12(b) Security	Common stock, $0.001 par value
Trading Symbol	CRUS
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		53,144,927
Amendment Flag	false
Document Fiscal Year Focus	2025
Document Fiscal Period Focus	Q3
Current Fiscal Year End Date	--03-29
Entity Central Index Key	0000772406

Consolidated Condensed Balance

Consolidated Condensed Balance Sheets - USD ($) $ in Thousands	Dec. 28, 2024	Mar. 30, 2024
Current assets:
Cash and cash equivalents	$ 526,444	$ 502,764
Marketable securities	37,535	23,778
Accounts receivable, net	261,943	162,478
Inventories	275,558	227,248
Prepaid assets	51,323	48,047
Prepaid wafers	66,113	86,679
Other current assets	31,534	55,198
Total current assets	1,250,450	1,106,192
Long-term marketable securities	252,594	173,374
Right-of-use lease assets	129,597	138,288
Property and equipment, net	163,837	170,175
Intangibles, net	23,957	29,578
Goodwill	435,936	435,936
Deferred tax assets	40,895	48,649
Long-term prepaid wafers	23,020	60,750
Other assets	42,954	68,634
Total assets	2,363,240	2,231,576
Current liabilities:
Accounts payable	77,907	55,545
Accrued salaries and benefits	48,029	47,612
Software license agreements	26,985	31,866
Current lease liabilities	21,858	20,640
Other accrued liabilities	36,134	30,730
Total current liabilities	210,913	186,393
Long-term liabilities:
Non-current lease liabilities	124,622	134,576
Non-current income taxes	43,401	52,013
Software license agreements	21,506	41,073
Other long-term liabilities	0	507
Total long-term liabilities	189,529	228,169
Stockholders' equity:
Capital stock	1,840,791	1,760,701
Accumulated earnings	124,101	58,916
Accumulated other comprehensive loss	(2,094)	(2,603)
Total stockholders' equity	1,962,798	1,817,014
Total liabilities and stockholders' equity	$ 2,363,240	$ 2,231,576

Consolidated Condensed Statemen

Consolidated Condensed Statements of Income - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 28, 2024	Dec. 30, 2023	Dec. 28, 2024	Dec. 30, 2023
Income Statement [Abstract]
Net sales	$ 555,738	$ 618,984	$ 1,471,621	$ 1,417,063
Cost of sales	257,951	301,520	702,319	693,616
Gross profit	297,787	317,464	769,302	723,447
Operating expenses
Research and development	112,976	112,672	331,264	323,092
Selling, general and administrative	39,042	37,604	113,625	107,306
Restructuring costs	0	(360)	0	1,959
Total operating expenses	152,018	149,916	444,889	432,357
Income from operations	145,769	167,548	324,413	291,090
Interest income	8,364	5,124	25,162	13,914
Interest expense	(218)	(235)	(680)	(696)
Other income (expense)	(214)	(337)	1,414	(30)
Income before income taxes	153,701	172,100	350,309	304,278
Provision for income taxes	37,696	33,377	90,069	74,548
Net income	$ 116,005	$ 138,723	$ 260,240	$ 229,730
Basic earnings per share (in dollars per share)	$ 2.19	$ 2.57	$ 4.89	$ 4.22
Diluted earnings per share (in dollars per share)	$ 2.11	$ 2.50	$ 4.69	$ 4.09
Basic weighted average common shares outstanding (in shares)	53,081	54,016	53,263	54,449
Diluted weighted average common shares outstanding (in shares)	55,076	55,592	55,529	56,160

Consolidated Condensed Statem_2

Consolidated Condensed Statements of Comprehensive Income - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 28, 2024	Dec. 30, 2023	Dec. 28, 2024	Dec. 30, 2023
Statement of Comprehensive Income [Abstract]
Net income	$ 116,005	$ 138,723	$ 260,240	$ 229,730
Other comprehensive loss, before tax
Foreign currency translation gain (loss)	(937)	445	(578)	(347)
Unrealized gain (loss) on marketable securities	(3,116)	1,266	1,377	1,505
Benefit (provision) for income taxes	654	(266)	(290)	(316)
Comprehensive income	$ 112,606	$ 140,168	$ 260,749	$ 230,572

Consolidated Condensed Statem_3

Consolidated Condensed Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Dec. 28, 2024	Dec. 30, 2023
Cash flows from operating activities:
Net income	$ 260,240	$ 229,730
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	37,801	36,283
Stock-based compensation expense	64,655	67,113
Deferred income taxes	7,466	1,122
Loss on retirement or write-off of long-lived assets	381	74
Other non-cash adjustments	812	2,276
Restructuring costs	0	1,959
Net change in operating assets and liabilities:
Accounts receivable	(99,465)	(67,558)
Inventories	(48,310)	(23,223)
Prepaid wafers	58,296	36,654
Other assets	(4,080)	11,682
Accounts payable and other accrued liabilities	17,749	(32,201)
Income taxes payable	18,435	8,598
Acquisition-related liabilities	0	(21,361)
Net cash provided by operating activities	313,980	251,148
Cash flows from investing activities:
Maturities and sales of available-for-sale marketable securities	25,904	23,418
Purchases of available-for-sale marketable securities	(117,505)	(53,525)
Purchases of property, equipment and software	(19,347)	(30,593)
Investments in technology	(225)	(57)
Net cash used in investing activities	(111,173)	(60,757)
Cash flows from financing activities:
Net proceeds from the issuance of common stock	15,433	610
Repurchase of stock to satisfy employee tax withholding obligations	(33,538)	(16,851)
Repurchase and retirement of common stock	(161,022)	(136,003)
Net cash used in financing activities	(179,127)	(152,244)
Net increase in cash and cash equivalents	23,680	38,147
Cash and cash equivalents at beginning of period	502,764	445,784
Cash and cash equivalents at end of period	$ 526,444	$ 483,931

Consolidated Condensed Statem_4

Consolidated Condensed Statements of Stockholders' Equity - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Earnings (Deficit)	Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Mar. 25, 2023		55,098
Beginning balance at Mar. 25, 2023	$ 1,658,282	$ 55	$ 1,670,086	$ (9,320)	$ (2,539)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	229,730			229,730
Change in unrealized gain (loss) on marketable securities, net of tax	1,189				1,189
Change in foreign currency translation adjustments	(347)				(347)
Issuance of stock under stock option plans and other, net of shares withheld for employee taxes (in shares)		589
Issuance of stock under stock option plans and other, net of shares withheld for employee taxes	(16,233)	$ 1	611	(16,845)
Repurchase and retirement of common stock (in shares)		(1,758)
Repurchase and retirement of common stock	(136,934)	$ (2)		(136,932)
Stock-based compensation	65,073		65,073
Ending balance (in shares) at Dec. 30, 2023		53,929
Ending balance at Dec. 30, 2023	1,800,760	$ 54	1,735,770	66,633	(1,697)
Beginning balance (in shares) at Sep. 23, 2023		54,237
Beginning balance at Sep. 23, 2023	1,708,355	$ 54	1,712,656	(1,213)	(3,142)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	138,723			138,723
Change in unrealized gain (loss) on marketable securities, net of tax	1,000				1,000
Change in foreign currency translation adjustments	445				445
Issuance of stock under stock option plans and other, net of shares withheld for employee taxes (in shares)		473
Issuance of stock under stock option plans and other, net of shares withheld for employee taxes	(13,671)	$ 1	47	(13,719)
Repurchase and retirement of common stock (in shares)		(781)
Repurchase and retirement of common stock	(57,159)	$ (1)		(57,158)
Stock-based compensation	23,067		23,067
Ending balance (in shares) at Dec. 30, 2023		53,929
Ending balance at Dec. 30, 2023	1,800,760	$ 54	1,735,770	66,633	(1,697)
Beginning balance (in shares) at Mar. 30, 2024		53,491
Beginning balance at Mar. 30, 2024	1,817,014	$ 53	1,760,648	58,916	(2,603)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	260,240			260,240
Change in unrealized gain (loss) on marketable securities, net of tax	1,087				1,087
Change in foreign currency translation adjustments	(578)				(578)
Issuance of stock under stock option plans and other, net of shares withheld for employee taxes (in shares)		1,044
Issuance of stock under stock option plans and other, net of shares withheld for employee taxes	(18,102)	$ 1	15,435	(33,538)
Repurchase and retirement of common stock (in shares)		(1,397)
Repurchase and retirement of common stock	(161,518)	$ (1)		(161,517)
Stock-based compensation	64,655		64,655
Ending balance (in shares) at Dec. 28, 2024		53,138
Ending balance at Dec. 28, 2024	1,962,798	$ 53	1,840,738	124,101	(2,094)
Beginning balance (in shares) at Sep. 28, 2024		53,132
Beginning balance at Sep. 28, 2024	1,928,127	$ 53	1,819,536	107,233	1,305
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	116,005			116,005
Change in unrealized gain (loss) on marketable securities, net of tax	(2,462)				(2,462)
Change in foreign currency translation adjustments	(937)				(937)
Issuance of stock under stock option plans and other, net of shares withheld for employee taxes (in shares)		685
Issuance of stock under stock option plans and other, net of shares withheld for employee taxes	(28,732)	$ 1	379	(29,112)
Repurchase and retirement of common stock (in shares)		(679)
Repurchase and retirement of common stock	(70,026)	$ (1)		(70,025)
Stock-based compensation	20,823		20,823
Ending balance (in shares) at Dec. 28, 2024		53,138
Ending balance at Dec. 28, 2024	$ 1,962,798	$ 53	$ 1,840,738	$ 124,101	$ (2,094)

Basis of Presentation

Basis of Presentation	9 Months Ended
	Dec. 28, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	Basis of PresentationThe unaudited consolidated condensed financial statements have been prepared by Cirrus Logic, Inc. (“Cirrus Logic,” “we,” “us,” “our,” or the “Company”) pursuant to the rules and regulations of the Securities and Exchange Commission (the “Commission”).  The accompanying unaudited consolidated condensed financial statements do not include complete footnotes and financial presentations.  As a result, these financial statements should be read along with the audited consolidated financial statements and notes thereto for the year ended March 30, 2024, included in our Annual Report on Form 10-K filed with the Commission on May 24, 2024.  In our opinion, the financial statements reflect all material adjustments, including normal recurring adjustments, necessary for a fair presentation of the financial position, operating results and cash flows for those periods presented.  The preparation of financial statements in conformity with United States (“U.S.”) generally accepted accounting principles (“GAAP”) requires management to make estimates and assumptions that affect reported assets, liabilities, revenues and expenses.  Actual results could differ from those estimates and assumptions.  Moreover, the results of operations for the interim periods presented are not necessarily indicative of the results that may be expected for the entire year.

Recently Issued Accounting Pron

Recently Issued Accounting Pronouncements	9 Months Ended
	Dec. 28, 2024
Accounting Policies [Abstract]
Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. This ASU requires (1) interim and annual disclosure of significant segment expenses that are regularly provided to the chief operating decision maker ("CODM") and included within each reported measure of a segment’s profit or loss, (2) interim disclosures about a reportable segment’s profit or loss and assets that are currently required annually, and (3) disclosure of the position and title of the CODM and how the CODM uses segment profit or loss information in assessing segment performance and deciding how to allocate resources. In the event the CODM uses more than one measure of a segment's profit or loss in assessing performance and allocation of resources, clarification of disclosure requirements is provided. Additionally, a company with a single reportable segment is required to provide all the disclosures prescribed under this ASU. The guidance is effective for annual periods beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, to be applied retrospectively to all periods presented, with early adoption permitted. The Company is currently evaluating the impact of this new guidance on financial statement disclosures . In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740) - Improvements to Income Tax Disclosures . The guidance provides qualitative and quantitative updates to the rate reconciliation and income taxes paid disclosures, requiring more consistent categories and greater disaggregation of information by jurisdiction. This ASU is effective for financial statements issued for annual periods beginning after December 15, 2024, with early adoption permitted, to be applied on a prospective basis, although retrospective application is also permitted. The Company is currently evaluating the impact of this guidance on financial statement disclosures. In November 2024, FASB issued ASU 2024-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Topic 220-40): Disaggregation of Income Statement Expenses , which requires disaggregation of certain expense categories in the notes to the financial statements in order to provide enhanced transparency into the expense captions presented on the face of the income statement. The amendments are effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027, with early adoption and prospective or retrospective application permitted. The Company is currently evaluating the impact of this guidance on financial statement disclosures.

Marketable Securities

Marketable Securities	9 Months Ended
	Dec. 28, 2024
Marketable Securities [Abstract]
Marketable Securities	Marketable Securities The Company’s investments have been classified as available-for-sale securities in accordance with U.S. GAAP. Marketable securities are categorized on the Consolidated Condensed Balance Sheet as " Marketable securities ", within the short-term or long-term classification, as appropriate, based on the original maturity. The following table is a summary of available-for-sale securities at December 28, 2024 (in thousands): As of December 28, 2024 Amortized Gross Gross Estimated Corporate debt securities $ 279,226 $ 820 $ (359) $ 279,687 U.S. Treasury securities 10,234 34 (10) 10,258 Agency discount notes 185 — (1) 184 Total securities $ 289,645 $ 854 $ (370) $ 290,129 The Company typically invests in highly-rated securities with original maturities generally ranging from one December 28, 2024. Securities in a continuous unrealized loss position for more than 12 months as of December 28, 2024 had an aggregate amortized cost of $4.3 million and an immaterial amount of aggregate unrealized loss. The Company may sell certain of its marketable securities prior to their stated maturities for strategic reasons including, but not limited to, anticipated or actual changes in credit rating and duration management. The Company records an allowance for credit loss when a decline in investment market value is due to credit-related factors. When evaluating an investment for impairment, the Company reviews factors including the length of time and extent to which fair value has been below cost basis, the financial condition of the issuer, changes in market interest rates and whether it is more likely than not the Company will be required to sell the investment before recovery of the investment’s cost basis. As of December 28, 2024, the Company does not consider any of its investments to be impaired. The following table is a summary of available-for-sale securities at March 30, 2024 (in thousands): As of March 30, 2024 Amortized Gross Gross Estimated Corporate debt securities $ 186,194 $ 115 $ (916) $ 185,393 U.S. Treasury securities 9,850 — (81) 9,769 Agency discount notes 1,135 — (11) 1,124 Commercial paper 866 — — 866 Total securities $ 198,045 $ 115 $ (1,008) $ 197,152 The Company's specifically identified gross unrealized losses of $1.0 million related to securities with total amortized costs of approximately $172.1 million at March 30, 2024. Securities in a continuous unrealized loss position for more than 12 months as of March 30, 2024 had an aggregate amortized cost of $25.0 million and an aggregate unrealized loss of $0.3 million. As of March 30, 2024, the Company did not consider any of its investments to be impaired. The cost and estimated fair value of available-for-sale securities by contractual maturities were as follows (in thousands): December 28, 2024 March 30, 2024 Amortized Estimated Amortized Estimated Cost Fair Value Cost Fair Value Within 1 year $ 37,490 $ 37,535 $ 24,071 $ 23,778 After 1 year 252,155 252,594 173,974 173,374 Total $ 289,645 $ 290,129 $ 198,045 $ 197,152

Fair Value of Financial Instrum

Fair Value of Financial Instruments	9 Months Ended
	Dec. 28, 2024
Fair Value Disclosures [Abstract]
Fair Value of Financial Instruments	Fair Value of Financial Instruments The Company has determined that the only material assets and liabilities in the Company’s financial statements that are required to be measured at fair value on a recurring basis are the Company’s cash equivalents and marketable securities portfolio. The Company defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The Company applies the following fair value hierarchy, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). • Level 1 - Quoted prices in active markets for identical assets or liabilities. • Level 2 - Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. • Level 3 - Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. The Company’s cash equivalents and marketable securities portfolio consist of money market funds, debt securities, U.S Treasury securities, securities of U.S. government-sponsored enterprises, and commercial paper and are reflected on our Consolidated Condensed Balance Sheets under the headings cash and cash equivalents, marketable securities, and long-term marketable securities. The Company determines the fair value of its marketable securities portfolio by obtaining non-binding market prices from third-party pricing providers on the last day of the quarter, whose sources may use quoted prices in active markets for identical assets (Level 1 inputs) or inputs other than quoted prices that are observable either directly or indirectly (Level 2 inputs) in determining fair value. The Company's long-term revolving credit facility, described in Note 8 - Revolving Credit Facility, bears interest at a base rate plus applicable margin or forward-looking secured overnight financing rate ("Term SOFR") plus 10 basis points plus applicable margin. As of December 28, 2024, there are no amounts drawn under the facility and the fair value is zero. As of December 28, 2024 and March 30, 2024, the Company has no Level 3 assets or liabilities. There were no transfers between Level 1, Level 2, or Level 3 measurements for the three months ended December 28, 2024. The following summarizes the fair value of our financial instruments at December 28, 2024 (in thousands): Quoted Prices Significant Significant Total Assets: Cash equivalents Money market funds $ 477,510 $ — $ — $ 477,510 Available-for-sale securities Corporate debt securities $ — $ 279,687 $ — $ 279,687 U.S. Treasury securities 10,258 — — 10,258 Agency discount notes — 184 — 184 $ 10,258 $ 279,871 $ — $ 290,129 The following summarizes the fair value of our financial instruments at March 30, 2024 (in thousands): Quoted Prices Significant Significant Total Assets: Cash equivalents Money market funds $ 439,065 $ — $ — $ 439,065 Certificates of deposit — 400 — 400 $ 439,065 $ 400 $ — $ 439,465 Available-for-sale securities Corporate debt securities $ — $ 185,393 $ — $ 185,393 U.S. Treasury securities 9,769 — — 9,769 Agency discount notes — 1,124 — 1,124 Commercial paper — 866 — 866 $ 9,769 $ 187,383 $ — $ 197,152

Derivative Financial Instrument

Derivative Financial Instruments	9 Months Ended
	Dec. 28, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Financial Instruments	Derivative Financial Instruments Foreign Currency Forward Contracts The Company uses foreign currency forward contracts to reduce the earnings impact that exchange rate fluctuations have on non-functional currency balance sheet exposures. The Company recognizes both the gains and losses on foreign currency forward contracts and the gains and losses on the remeasurement of non-functional currency assets and liabilities within " Other income (expense) " in the Consolidated Condensed Statements of Income. The Company does not apply hedge accounting to these foreign currency derivative instruments. As of December 28, 2024, the Company held one foreign currency forward contract denominated in British Pound Sterling with a notional value of $22.3 million. The fair value of this contract was not material as of December 28, 2024. The before-tax effect of derivative instruments not designated as hedging instruments was as follows (in thousands): Three Months Ended Nine Months Ended December 28, December 30, December 28, December 30, 2024 2023 2024 2023 Location Gain (loss) recognized in income: Foreign currency forward contracts $ (1,220) $ 88 $ (568) $ (384) Other income (expense)

Accounts Receivable, net

Accounts Receivable, net	9 Months Ended
	Dec. 28, 2024
Accounts Receivable, after Allowance for Credit Loss [Abstract]
Accounts Receivable, net	Accounts Receivable, net The following are the components of accounts receivable, net (in thousands): December 28, March 30, 2024 2024 Gross accounts receivable $ 261,943 $ 162,478 Allowance for doubtful accounts — — Accounts receivable, net $ 261,943 $ 162,478 The increase in accounts receivable is due to normal variations in the timing of collections and billings.

Inventories

Inventories	9 Months Ended
	Dec. 28, 2024
Inventory Disclosure [Abstract]
Inventories	Inventories Inventories are comprised of the following (in thousands): December 28, March 30, 2024 2024 Work in process $ 179,262 $ 130,842 Finished goods 96,296 96,406 $ 275,558 $ 227,248

Revolving Credit Facility

Revolving Credit Facility	9 Months Ended
	Dec. 28, 2024
Debt Disclosure [Abstract]
Revolving Credit Facility	Revolving Credit Facility On July 8, 2021, the Company entered into a second amended and restated credit agreement (the “Second Amended Credit Agreement”) with Wells Fargo Bank, National Association, as administrative agent, and the lenders party thereto. The Second Amended Credit Agreement provides for a $300 million senior secured revolving credit facility (the “Revolving Credit Facility”). The Revolving Credit Facility matures on July 8, 2026 (the “Maturity Date”). The Revolving Credit Facility is required to be guaranteed by all of Cirrus Logic’s material domestic subsidiaries (the "Subsidiary Guarantors"). The Revolving Credit Facility is secured by substantially all the assets of Cirrus Logic and any Subsidiary Guarantors, except for certain excluded assets. On March 20, 2023, the Company, entered into the First Amendment (the "Amendment") to its Second Amended Credit Agreement, with the lending institutions party thereto and Wells Fargo Bank, National Association, as administrative agent. The Amendment updates the benchmark interest rate provisions to replace the London interbank offered rate ("LIBOR") with the forward-looking secured overnight financing rate ("Term SOFR"), for the purposes of calculating interest under the terms of the Second Amended Credit Agreement. Borrowings under the Revolving Credit Facility may bear interest, at Cirrus Logic’s election, at either (a) a base rate plus the applicable margin ("Base Rate Loans") or (b) a Term SOFR rate plus a 10 basis point credit spread adjustment plus the applicable margin. The applicable margin ranges from 0% to 0.75% per annum for Base Rate Loans and 1.00% to 1.75% per annum for SOFR Loans based on the ratio of consolidated funded indebtedness to consolidated EBITDA for the most recently ended period of four consecutive fiscal quarters (the “Consolidated Leverage Ratio”). A Commitment Fee accrues at a rate per annum ranging from 0.175% to 0.275% (based on the Consolidated Leverage Ratio) on the average daily unused portion of the commitment of the lenders. The Revolving Credit Facility contains certain financial covenants providing that (a) the ratio of consolidated funded indebtedness (minus up to $200 million of unrestricted cash and cash equivalents available on such date) to consolidated EBITDA for the prior four consecutive quarters must not be greater than 3.00 to 1.00 (the “Consolidated Net Leverage Ratio”) and (b) the ratio of consolidated EBITDA for the prior four consecutive quarters to consolidated interest expense paid or payable in cash for the prior four consecutive quarters must not be less than 3.00 to 1.00 (the “Consolidated Interest Coverage Ratio”). The Second Amended Credit Agreement also contains customary negative covenants limiting the ability of Cirrus Logic or any Subsidiary to, among other things, incur debt, grant liens, make investments, effect certain fundamental changes, make certain asset dispositions, and make certain restricted payments. Further, the Second Amended Credit Agreement contains customary affirmative covenants, including, among others, covenants regarding the payment of taxes and other obligations, maintenance of insurance, reporting requirements, and compliance with applicable laws and regulations. As of December 28, 2024, the Company had no amounts outstanding under the Revolving Credit Facility and was in compliance with all covenants under the Second Amended Credit Agreement.

Revenues

Revenues	9 Months Ended
	Dec. 28, 2024
Revenue from Contract with Customer [Abstract]
Revenues	Revenues Disaggregation of revenue We disaggregate revenue from contracts with customers by product line and ship to location of the customer. Sales are designated in the respective product line categories of Audio and High-Performance Mixed-Signal ("HPMS"). Total net sales based on the product line disaggregation criteria described above are shown in the table below (in thousands). Three Months Ended Nine Months Ended December 28, December 30, December 28, December 30, 2024 2023 2024 2023 Audio Products $ 346,272 $ 378,597 $ 881,830 $ 857,258 HPMS Products 209,466 240,387 589,791 559,805 $ 555,738 $ 618,984 $ 1,471,621 $ 1,417,063 The geographic regions that are reviewed are China, the United States, and the rest of the world. Total net sales based on the geographic disaggregation criteria described are as follows (in thousands): Three Months Ended Nine Months Ended December 28, December 30, December 28, December 30, 2024 2023 2024 2023 China $ 373,449 $ 429,240 $ 904,899 $ 899,168 United States 5,638 9,115 13,325 16,157 Rest of World 176,651 180,629 553,397 501,738 $ 555,738 $ 618,984 $ 1,471,621 $ 1,417,063

Restructuring Costs

Restructuring Costs	9 Months Ended
	Dec. 28, 2024
Restructuring and Related Activities [Abstract]
Restructuring Costs	Restructuring Costs In fiscal year 2023, the Company decided to abandon or sublease office space at various properties worldwide to align our real property lease arrangements with our anticipated operating needs. In addition, in fiscal year 2024, the Company announced a workforce reduction of approximately 5% of its global employees. The Company incurred associated severance and other related charges of $2.3 million in the second quarter of fiscal year 2024. In the third quarter of fiscal year 2024, a recovery of restructuring costs of $0.4 million was recorded for the settlement of certain lease obligations related to abandoned office space associated with the fiscal year 2023 restructuring event. As of December 28, 2024, remaining restructuring-related liabilities were immaterial and are expected to be substantially paid out in cash during fiscal year 2025.

Income Taxes

Income Taxes	9 Months Ended
	Dec. 28, 2024
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes Our provision for income taxes is based on estimated effective tax rates derived from an estimate of annual consolidated earnings before taxes, adjusted for nondeductible expenses, other permanent items, and any applicable income tax credits. The following table presents the provision for income taxes (in thousands) and the effective tax rates: Three Months Ended Nine Months Ended December 28, December 30, December 28, December 30, 2024 2023 2024 2023 Income before income taxes $ 153,701 $ 172,100 $ 350,309 $ 304,278 Provision for income taxes $ 37,696 $ 33,377 $ 90,069 $ 74,548 Effective tax rate 24.5 % 19.4 % 25.7 % 24.5 % Our income tax expense was $37.7 million and $33.4 million for the third quarters of fiscal years 2025 and 2024, respectively, resulting in effective tax rates of 24.5 percent and 19.4 percent, respectively. Our income tax expense was $90.1 million and $74.5 million for the first nine months of fiscal years 2025 and 2024, respectively, resulting in effective tax rates of 25.7 percent and 24.5 percent, respectively. Effective tax rates for all periods presented were unfavorably impacted by a provision in the Tax Cuts and Jobs Act of 2017 that requires research and development ("R&D") expenditures incurred in tax years beginning after December 31, 2021 to be capitalized and amortized ratably over five or fifteen years depending on the location in which the research activities are conducted, resulting in higher global intangible low-taxed income ("GILTI"), which is treated as a period cost. In addition, our effective tax rates for all periods presented were unfavorably impacted by U.S. tax rules related to refundable tax credits, including R&D expenditure credits available to us in the United Kingdom, that reduce the amount of foreign tax credits available to offset GILTI. Our effective tax rates for the third quarter of fiscal year 2025 and the first nine months of fiscal years 2025 and 2024, respectively, were higher than the federal statutory rate primarily due to these two items, partially offset by the effect of income earned in certain foreign jurisdictions that is taxed below the federal statutory rate. Our effective rate for the third quarter of fiscal year 2024 was lower than the federal statutory rate due to a one-time tax benefit recorded during that period for a change in capitalized R&D expenditures that decreased GILTI inclusions in our fiscal year 2023 U.S. tax return. The Company records unrecognized tax benefits for the estimated risk associated with tax positions taken on tax returns. At December 28, 2024, the Company had unrecognized tax benefits of $32.1 million, all of which would impact the effective tax rate if recognized. The Company’s total unrecognized tax benefits are classified as “ Non-current income taxes" in the Consolidated Condensed Balance Sheets. The Company recognizes interest and penalties related to unrecognized tax benefits in the provision for income taxes. As of December 28, 2024, the balance of accrued interest and penalties, net of tax, was $11.3 million. On July 27, 2015, the U.S. Tax Court issued an opinion in Altera Corp. et al. v. Commissioner which concluded that the regulations relating to the treatment of stock-based compensation expense in intercompany cost-sharing arrangements were invalid. In 2016 the U.S. Internal Revenue Service appealed the decision to the U.S. Court of Appeals for the Ninth Circuit (the “Ninth Circuit”). On June 7, 2019, the Ninth Circuit reversed the decision of the U.S. Tax Court and upheld the cost-sharing regulations. On February 10, 2020, Altera Corp. filed a Petition for a Writ of Certiorari with the Supreme Court of the United States, which was denied by the Supreme Court on June 22, 2020. Although the issue is now resolved in the Ninth Circuit, the Ninth Circuit's opinion is not binding in other circuits. The potential impact of this issue on the Company, which is not located within the jurisdiction of the Ninth Circuit, is unclear at this time. We will continue to monitor developments related to this issue and the potential impact of those developments on the Company's current and prior fiscal years. The Company and its subsidiaries are subject to U.S. federal income tax as well as income tax in multiple state and foreign jurisdictions. Fiscal years 2017 through 2019 and 2021 through 2024 remain open to examination by the major taxing jurisdictions in which the Company operates. The Company's fiscal year 2017, 2018, and 2019 federal income tax returns are under examination by the U.S. Internal Revenue Service ("IRS"). The IRS has proposed adjustments that would increase U.S. taxable income related to transfer pricing matters with respect to our U.S. and U.K. affiliated companies. The final Revenue Agent’s Report asserted additional tax of approximately $168.3 million, excluding interest, and imposed penalties of approximately $63.7 million. The Company does not agree with the IRS's positions and has not accrued an additional liability. In July 2024, the Company entered the administrative dispute process with the IRS Independent Office of Appeals ("IRS Appeals"). We intend to vigorously dispute the proposed adjustments and pursue judicial remedies if an acceptable outcome cannot be reached with IRS Appeals. The Company expects it could take a number of years to reach resolution on these matters. Although the final resolution of these matters is uncertain, the Company believes adequate amounts have been reserved in accordance with ASC 740 for any adjustments to the provision for income taxes that may ultimately result. However, if the IRS prevails in these matters, the ultimate amount of assessed tax, interest, and penalties, if any, could be material and may have an adverse impact on our financial position, results of operations, and cash flows in future periods. The Company is not under an income tax audit in any other major taxing jurisdiction.

Net Income Per Share

Net Income Per Share	9 Months Ended
	Dec. 28, 2024
Earnings Per Share [Abstract]
Net Income Per Share	Net Income Per Share Basic net income per share is based on the weighted effect of common shares issued and outstanding and is calculated by dividing net income by the basic weighted average shares outstanding during the period. Diluted net income per share is calculated by dividing net income by the weighted average number of common shares used in the basic net income per share calculation, plus the equivalent number of common shares that would be issued assuming exercise or conversion of all potentially dilutive common shares outstanding. These potentially dilutive items consist primarily of outstanding stock options and restricted stock units. The following table details the calculation of basic and diluted earnings per share for the three and nine months ended December 28, 2024 and December 30, 2023 (in thousands, except per share amounts): Three Months Ended Nine Months Ended December 28, December 30, December 28, December 30, 2024 2023 2024 2023 Numerator: Net income $ 116,005 $ 138,723 $ 260,240 $ 229,730 Denominator: Weighted average shares outstanding 53,081 54,016 53,263 54,449 Effect of dilutive securities 1,995 1,576 2,266 1,711 Weighted average diluted shares 55,076 55,592 55,529 56,160 Basic earnings per share $ 2.19 $ 2.57 $ 4.89 $ 4.22 Diluted earnings per share $ 2.11 $ 2.50 $ 4.69 $ 4.09 The weighted outstanding shares excluded from our diluted calculation for the three and nine months ended December 28, 2024 were 228 thousand and 224 thousand, respectively, as the shares were anti-dilutive. The weighted outstanding shares excluded from our diluted calculation for the three and nine months ended December 30, 2023 were 388 thousand and 394 thousand, respectively, as the shares were anti-dilutive.

Commitment and Contingencies

Commitment and Contingencies	9 Months Ended
	Dec. 28, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Capacity Reservation Agreement On July 28, 2021, the Company entered into a Capacity Reservation and Wafer Supply Commitment Agreement (the “Capacity Reservation Agreement”) with GlobalFoundries to provide the Company a wafer capacity commitment and wafer pricing for Company products for calendar years 2022-2026 (the “Commitment Period”). The Capacity Reservation Agreement requires GlobalFoundries to provide, and the Company to purchase, a defined number of wafers on a quarterly basis for the Commitment Period, subject to shortfall payments. In exchange for GlobalFoundries’ capacity commitment, the Company paid a $60 million non-refundable capacity reservation fee, which is amortized over the Commitment Period. The balance of this reservation fee is $20 million as of December 28, 2024, and is recorded in " Other current assets " and " Other assets " on the Consolidated Condensed Balance Sheets within the short-term or long-term classification, as appropriate. In addition, the Company pre-paid GlobalFoundries $195 million for future wafer purchases, which are credited back to the Company as a portion of the price of wafers purchased, which began in the Company's second fiscal quarter of 2024. The balance of the prepayment is $89 million at December 28, 2024, and is currently recorded in " Long-term prepaid wafers " and " Prepaid wafers " on the Consolidated Condensed Balance Sheets.

Legal Matters

Legal Matters	9 Months Ended
	Dec. 28, 2024
Loss Contingency, Information about Litigation Matters [Abstract]
Legal Matters	Legal Matters From time to time, we are involved in legal proceedings concerning matters arising in connection with the conduct of our business activities. We regularly evaluate the status of legal proceedings in which we are involved in order to assess whether a loss is probable or there is a reasonable possibility that a loss or additional loss may have been incurred, and to determine if accruals are appropriate. We further evaluate each legal proceeding to assess whether an estimate of possible loss or range of loss can be made. Based on current knowledge, management does not believe that there are any pending matters that could potentially have a material adverse effect on our business, financial condition, results of operations or cash flows. However, we are engaged in various legal actions in the normal course of business. There can be no assurances in light of the inherent uncertainties involved in any potential legal proceedings, some of which are beyond our control, and an adverse outcome in any legal proceeding could be material to our results of operations or cash flows for any particular reporting period.

Stockholders' Equity

Stockholders' Equity	9 Months Ended
	Dec. 28, 2024
Stockholders' Equity Note [Abstract]
Stockholders' Equity	Stockholders' Equity Common Stock The Company issued a net 0.7 million and 1.0 million of shares of common stock during each of the three and nine months ended December 28, 2024, and issued a net 0.5 million and 0.6 million of shares of common stock for the three and nine months ended December 30, 2023 pursuant to the Company's equity incentive plans. Share Repurchase Program The Company's net stock repurchases are subject to a 1 percent excise tax under the Inflation Reduction Act, which is included as a reduction to accumulated earnings in the Consolidated Condensed Statements of Stockholders' Equity. As of December 28, 2024, the Company has accrued approximately $0.5 million related to this excise tax. Disclosure of repurchased amounts and related average costs exclude the impact of excise taxes. In July 2022, the Board of Directors authorized the repurchase of up to $500 million of the Company's common stock . A s of December 28, 2024, a pproximately $345.9 million of the Company's common stock has been repurchased under the share repurchase authorization, leaving approximately $154.1 million available for repurchase. During the three months ended December 28, 2024, the Company repurchased 0.7 million shares of the Company's common stock for $70.0 million, at an average cost of $103.18 per share. During the nine months ended December 28, 2024, the Company repurchased 1.4 million shares of the Company's common stock for $161.0 million, at an average cost of $115.31 per share.

Segment Information

Segment Information	9 Months Ended
	Dec. 28, 2024
Segment Reporting [Abstract]
Segment Information	Segment Information We determine our operating segments in accordance with FASB guidelines. Our Chief Executive Officer (“CEO”) has been identified as the chief operating decision maker under these guidelines. The Company operates and tracks its results in one reportable segment, but reports revenue in two product lines, Audio and HPMS. Our CEO receives and uses enterprise-wide financial information to assess financial performance and allocate resources, rather than detailed information at a product line level. Additionally, our product lines have similar characteristics and customers. They share support functions such as sales, public relations, supply chain management, various research and development and engineering support, in addition to the general and administrative functions of human resources, legal, finance and information technology. Therefore, there is no complete, discrete financial information maintained for these product lines. Revenue by product line is disclosed in Note 9 - Revenues.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 28, 2024	Dec. 30, 2023	Dec. 28, 2024	Dec. 30, 2023
Pay vs Performance Disclosure
Net income	$ 116,005	$ 138,723	$ 260,240	$ 229,730

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Dec. 28, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Recently Issued Accounting Pr_2

Recently Issued Accounting Pronouncements (Policies)	9 Months Ended
	Dec. 28, 2024
Accounting Policies [Abstract]
Recently Issued Accounting Pronouncements	In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. This ASU requires (1) interim and annual disclosure of significant segment expenses that are regularly provided to the chief operating decision maker ("CODM") and included within each reported measure of a segment’s profit or loss, (2) interim disclosures about a reportable segment’s profit or loss and assets that are currently required annually, and (3) disclosure of the position and title of the CODM and how the CODM uses segment profit or loss information in assessing segment performance and deciding how to allocate resources. In the event the CODM uses more than one measure of a segment's profit or loss in assessing performance and allocation of resources, clarification of disclosure requirements is provided. Additionally, a company with a single reportable segment is required to provide all the disclosures prescribed under this ASU. The guidance is effective for annual periods beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, to be applied retrospectively to all periods presented, with early adoption permitted. The Company is currently evaluating the impact of this new guidance on financial statement disclosures . In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740) - Improvements to Income Tax Disclosures . The guidance provides qualitative and quantitative updates to the rate reconciliation and income taxes paid disclosures, requiring more consistent categories and greater disaggregation of information by jurisdiction. This ASU is effective for financial statements issued for annual periods beginning after December 15, 2024, with early adoption permitted, to be applied on a prospective basis, although retrospective application is also permitted. The Company is currently evaluating the impact of this guidance on financial statement disclosures. In November 2024, FASB issued ASU 2024-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Topic 220-40): Disaggregation of Income Statement Expenses , which requires disaggregation of certain expense categories in the notes to the financial statements in order to provide enhanced transparency into the expense captions presented on the face of the income statement. The amendments are effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027, with early adoption and prospective or retrospective application permitted. The Company is currently evaluating the impact of this guidance on financial statement disclosures.
Marketable Securities	The Company’s investments have been classified as available-for-sale securities in accordance with U.S. GAAP. Marketable securities are categorized on the Consolidated Condensed Balance Sheet as " Marketable securities
Fair Value of Financial Instruments	The Company has determined that the only material assets and liabilities in the Company’s financial statements that are required to be measured at fair value on a recurring basis are the Company’s cash equivalents and marketable securities portfolio. The Company defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The Company applies the following fair value hierarchy, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). • Level 1 - Quoted prices in active markets for identical assets or liabilities. • Level 2 - Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. • Level 3 - Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. The Company’s cash equivalents and marketable securities portfolio consist of money market funds, debt securities, U.S Treasury securities, securities of U.S. government-sponsored enterprises, and commercial paper and are reflected on our Consolidated Condensed Balance Sheets under the headings cash and cash equivalents, marketable securities, and long-term marketable securities. The Company determines the fair value of its marketable securities portfolio by obtaining non-binding market prices from third-party pricing providers on the last day of the quarter, whose sources may use quoted prices in active markets for identical assets (Level 1 inputs) or inputs other than quoted prices that are observable either directly or indirectly (Level 2 inputs) in determining fair value.
Revenues	Disaggregation of revenue We disaggregate revenue from contracts with customers by product line and ship to location of the customer. Sales are designated in the respective product line categories of Audio and High-Performance Mixed-Signal ("HPMS").
Segment Information	We determine our operating segments in accordance with FASB guidelines. Our Chief Executive Officer (“CEO”) has been identified as the chief operating decision maker under these guidelines. The Company operates and tracks its results in one reportable segment, but reports revenue in two product lines, Audio and HPMS. Our CEO receives and uses enterprise-wide financial information to assess financial performance and allocate resources, rather than detailed information at a product line level. Additionally, our product lines have similar characteristics and customers. They share support functions such as sales, public relations, supply chain management, various research and development and engineering support, in addition to the general and administrative functions of human resources, legal, finance and information technology. Therefore, there is no complete, discrete financial information maintained for these product lines. Revenue by product line is disclosed in Note 9 - Revenues.

Marketable Securities (Tables)

Marketable Securities (Tables)	9 Months Ended
	Dec. 28, 2024
Marketable Securities [Abstract]
Schedule of Available-for-sale Securities	The following table is a summary of available-for-sale securities at December 28, 2024 (in thousands): As of December 28, 2024 Amortized Gross Gross Estimated Corporate debt securities $ 279,226 $ 820 $ (359) $ 279,687 U.S. Treasury securities 10,234 34 (10) 10,258 Agency discount notes 185 — (1) 184 Total securities $ 289,645 $ 854 $ (370) $ 290,129 The following table is a summary of available-for-sale securities at March 30, 2024 (in thousands): As of March 30, 2024 Amortized Gross Gross Estimated Corporate debt securities $ 186,194 $ 115 $ (916) $ 185,393 U.S. Treasury securities 9,850 — (81) 9,769 Agency discount notes 1,135 — (11) 1,124 Commercial paper 866 — — 866 Total securities $ 198,045 $ 115 $ (1,008) $ 197,152
Schedule of Cost and Estimated Fair Value of Available-for-sale Securities by Contractual Maturity	The cost and estimated fair value of available-for-sale securities by contractual maturities were as follows (in thousands): December 28, 2024 March 30, 2024 Amortized Estimated Amortized Estimated Cost Fair Value Cost Fair Value Within 1 year $ 37,490 $ 37,535 $ 24,071 $ 23,778 After 1 year 252,155 252,594 173,974 173,374 Total $ 289,645 $ 290,129 $ 198,045 $ 197,152

Fair Value of Financial Instr_2

Fair Value of Financial Instruments (Tables)	9 Months Ended
	Dec. 28, 2024
Fair Value Disclosures [Abstract]
Schedule of Fair Value of Financial Assets and Liabilities	The following summarizes the fair value of our financial instruments at December 28, 2024 (in thousands): Quoted Prices Significant Significant Total Assets: Cash equivalents Money market funds $ 477,510 $ — $ — $ 477,510 Available-for-sale securities Corporate debt securities $ — $ 279,687 $ — $ 279,687 U.S. Treasury securities 10,258 — — 10,258 Agency discount notes — 184 — 184 $ 10,258 $ 279,871 $ — $ 290,129 The following summarizes the fair value of our financial instruments at March 30, 2024 (in thousands): Quoted Prices Significant Significant Total Assets: Cash equivalents Money market funds $ 439,065 $ — $ — $ 439,065 Certificates of deposit — 400 — 400 $ 439,065 $ 400 $ — $ 439,465 Available-for-sale securities Corporate debt securities $ — $ 185,393 $ — $ 185,393 U.S. Treasury securities 9,769 — — 9,769 Agency discount notes — 1,124 — 1,124 Commercial paper — 866 — 866 $ 9,769 $ 187,383 $ — $ 197,152

Derivative Financial Instrume_2

Derivative Financial Instruments (Tables)	9 Months Ended
	Dec. 28, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Before-Tax Effect of Derivative Instruments Not Designated as Hedging Instruments	The before-tax effect of derivative instruments not designated as hedging instruments was as follows (in thousands): Three Months Ended Nine Months Ended December 28, December 30, December 28, December 30, 2024 2023 2024 2023 Location Gain (loss) recognized in income: Foreign currency forward contracts $ (1,220) $ 88 $ (568) $ (384) Other income (expense)

Accounts Receivable, net (Table

Accounts Receivable, net (Tables)	9 Months Ended
	Dec. 28, 2024
Accounts Receivable, after Allowance for Credit Loss [Abstract]
Components of Accounts Receivable, net	The following are the components of accounts receivable, net (in thousands): December 28, March 30, 2024 2024 Gross accounts receivable $ 261,943 $ 162,478 Allowance for doubtful accounts — — Accounts receivable, net $ 261,943 $ 162,478

Inventories (Tables)

Inventories (Tables)	9 Months Ended
	Dec. 28, 2024
Inventory Disclosure [Abstract]
Schedule of Inventories	Inventories are comprised of the following (in thousands): December 28, March 30, 2024 2024 Work in process $ 179,262 $ 130,842 Finished goods 96,296 96,406 $ 275,558 $ 227,248

Revenues (Tables)

Revenues (Tables)	9 Months Ended
	Dec. 28, 2024
Revenue from Contract with Customer [Abstract]
Disaggregation of Revenue	Total net sales based on the product line disaggregation criteria described above are shown in the table below (in thousands). Three Months Ended Nine Months Ended December 28, December 30, December 28, December 30, 2024 2023 2024 2023 Audio Products $ 346,272 $ 378,597 $ 881,830 $ 857,258 HPMS Products 209,466 240,387 589,791 559,805 $ 555,738 $ 618,984 $ 1,471,621 $ 1,417,063 The geographic regions that are reviewed are China, the United States, and the rest of the world. Total net sales based on the geographic disaggregation criteria described are as follows (in thousands): Three Months Ended Nine Months Ended December 28, December 30, December 28, December 30, 2024 2023 2024 2023 China $ 373,449 $ 429,240 $ 904,899 $ 899,168 United States 5,638 9,115 13,325 16,157 Rest of World 176,651 180,629 553,397 501,738 $ 555,738 $ 618,984 $ 1,471,621 $ 1,417,063

Income Taxes (Tables)

Income Taxes (Tables)	9 Months Ended
	Dec. 28, 2024
Income Tax Disclosure [Abstract]
Schedule of Provision for Income Taxes and Effective Tax Rates	The following table presents the provision for income taxes (in thousands) and the effective tax rates: Three Months Ended Nine Months Ended December 28, December 30, December 28, December 30, 2024 2023 2024 2023 Income before income taxes $ 153,701 $ 172,100 $ 350,309 $ 304,278 Provision for income taxes $ 37,696 $ 33,377 $ 90,069 $ 74,548 Effective tax rate 24.5 % 19.4 % 25.7 % 24.5 %

Net Income Per Share (Tables)

Net Income Per Share (Tables)	9 Months Ended
	Dec. 28, 2024
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted	The following table details the calculation of basic and diluted earnings per share for the three and nine months ended December 28, 2024 and December 30, 2023 (in thousands, except per share amounts): Three Months Ended Nine Months Ended December 28, December 30, December 28, December 30, 2024 2023 2024 2023 Numerator: Net income $ 116,005 $ 138,723 $ 260,240 $ 229,730 Denominator: Weighted average shares outstanding 53,081 54,016 53,263 54,449 Effect of dilutive securities 1,995 1,576 2,266 1,711 Weighted average diluted shares 55,076 55,592 55,529 56,160 Basic earnings per share $ 2.19 $ 2.57 $ 4.89 $ 4.22 Diluted earnings per share $ 2.11 $ 2.50 $ 4.69 $ 4.09

Marketable Securities (Schedule

Marketable Securities (Schedule of Available-for-sale Securities) (Details) - USD ($) $ in Thousands	Dec. 28, 2024	Mar. 30, 2024
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	$ 289,645	$ 198,045
Gross Unrealized Gains	854	115
Gross Unrealized Losses	(370)	(1,008)
Estimated Fair Value (Net Carrying Amount)	290,129	197,152
Corporate debt securities
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	279,226	186,194
Gross Unrealized Gains	820	115
Gross Unrealized Losses	(359)	(916)
Estimated Fair Value (Net Carrying Amount)	279,687	185,393
U.S. Treasury securities
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	10,234	9,850
Gross Unrealized Gains	34	0
Gross Unrealized Losses	(10)	(81)
Estimated Fair Value (Net Carrying Amount)	10,258	9,769
Agency discount notes
Debt Securities, Available-for-sale [Line Items]
Amortized Cost	185	1,135
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(1)	(11)
Estimated Fair Value (Net Carrying Amount)	$ 184	1,124
Commercial paper
Debt Securities, Available-for-sale [Line Items]
Amortized Cost		866
Gross Unrealized Gains		0
Gross Unrealized Losses		0
Estimated Fair Value (Net Carrying Amount)		$ 866

Marketable Securities (Narrativ

Marketable Securities (Narrative) (Details) - USD ($) $ in Thousands	9 Months Ended
	Dec. 28, 2024	Mar. 30, 2024
Debt Securities, Available-for-sale [Line Items]
Gross unrealized losses	$ 370	$ 1,008
Amortized cost on available for sale securities held at gross unrealized loss	90,000	172,100
Securities in a continuous unrealized loss position for more than 12 months, amortized cost	$ 4,300	25,000
Securities in a continuous unrealized loss position for more than 12 months, aggregate unrealized loss		$ 300
Minimum
Debt Securities, Available-for-sale [Line Items]
Maturity period for highly-rated securities	1 year
Maximum
Debt Securities, Available-for-sale [Line Items]
Maturity period for highly-rated securities	3 years

Marketable Securities (Schedu_2

Marketable Securities (Schedule of Cost and Estimated Fair Value of Available-for-sale Securities by Contractual Maturity) (Details) - USD ($) $ in Thousands	Dec. 28, 2024	Mar. 30, 2024
Amortized Cost
Within 1 year	$ 37,490	$ 24,071
After 1 year	252,155	173,974
Amortized Cost	289,645	198,045
Estimated Fair Value
Within 1 year	37,535	23,778
After 1 year	252,594	173,374
Estimated Fair Value (Net Carrying Amount)	$ 290,129	$ 197,152

Fair Value of Financial Instr_3

Fair Value of Financial Instruments (Narrative) (Details) - USD ($)	Mar. 20, 2023	Dec. 28, 2024
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Amounts drawn under the credit facility		$ 0
Credit facility, fair value		$ 0
Second Amended Credit Agreement Revolving Credit Facility | Secured Overnight Financing Rate (SOFR) | Revolving Credit Facility | Line of Credit
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Basis spread on variable rate	0.10%

Fair Value of Financial Instr_4

Fair Value of Financial Instruments (Schedule of Fair Value of Financial Assets and Liabilities) (Details) - USD ($) $ in Thousands	Dec. 28, 2024	Mar. 30, 2024
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents		$ 439,465
Available-for-sale securities	$ 290,129	197,152
Quoted Prices in Active Markets for Identical Assets Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents		439,065
Available-for-sale securities	10,258	9,769
Significant Other Observable Inputs Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents		400
Available-for-sale securities	279,871	187,383
Significant Unobservable Inputs Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents		0
Available-for-sale securities	0	0
Corporate debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale securities	279,687	185,393
Corporate debt securities | Quoted Prices in Active Markets for Identical Assets Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale securities	0	0
Corporate debt securities | Significant Other Observable Inputs Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale securities	279,687	185,393
Corporate debt securities | Significant Unobservable Inputs Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale securities	0	0
U.S. Treasury securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale securities	10,258	9,769
U.S. Treasury securities | Quoted Prices in Active Markets for Identical Assets Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale securities	10,258	9,769
U.S. Treasury securities | Significant Other Observable Inputs Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale securities	0	0
U.S. Treasury securities | Significant Unobservable Inputs Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale securities	0	0
Agency discount notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale securities	184	1,124
Agency discount notes | Quoted Prices in Active Markets for Identical Assets Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale securities	0	0
Agency discount notes | Significant Other Observable Inputs Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale securities	184	1,124
Agency discount notes | Significant Unobservable Inputs Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale securities	0	0
Commercial paper
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale securities		866
Commercial paper | Quoted Prices in Active Markets for Identical Assets Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale securities		0
Commercial paper | Significant Other Observable Inputs Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale securities		866
Commercial paper | Significant Unobservable Inputs Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale securities		0
Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	477,510	439,065
Money market funds | Quoted Prices in Active Markets for Identical Assets Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	477,510	439,065
Money market funds | Significant Other Observable Inputs Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	0	0
Money market funds | Significant Unobservable Inputs Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	$ 0	0
Certificates of deposit
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents		400
Certificates of deposit | Quoted Prices in Active Markets for Identical Assets Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents		0
Certificates of deposit | Significant Other Observable Inputs Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents		400
Certificates of deposit | Significant Unobservable Inputs Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents		$ 0

Derivative Financial Instrume_3

Derivative Financial Instruments (Details) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 28, 2024 USD ($) derivativeContract	Dec. 30, 2023 USD ($)	Dec. 28, 2024 USD ($) derivativeContract	Dec. 30, 2023 USD ($)
Derivative Instruments, Gain (Loss) [Line Items]
Number of foreign currency derivatives held | derivativeContract	1		1
Notional value of foreign currency forward contract	$ 22,300		$ 22,300
Foreign currency forward contracts | Not Designated as Hedging Instrument
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) recognized in income	$ (1,220)	$ 88	$ (568)	$ (384)

Accounts Receivable, net (Detai

Accounts Receivable, net (Details) - USD ($) $ in Thousands	Dec. 28, 2024	Mar. 30, 2024
Accounts Receivable, after Allowance for Credit Loss [Abstract]
Gross accounts receivable	$ 261,943	$ 162,478
Allowance for doubtful accounts	0	0
Accounts receivable, net	$ 261,943	$ 162,478

Inventories (Details)

Inventories (Details) - USD ($) $ in Thousands	Dec. 28, 2024	Mar. 30, 2024
Inventory Disclosure [Abstract]
Work in process	$ 179,262	$ 130,842
Finished goods	96,296	96,406
Total inventories	$ 275,558	$ 227,248

Revolving Credit Facility (Deta

Revolving Credit Facility (Details) - Second Amended Credit Agreement Revolving Credit Facility - USD ($)	Mar. 20, 2023	Jul. 08, 2021	Dec. 28, 2024
Line of Credit Facility [Line Items]
Line of credit facility maximum borrowing capacity		$ 300,000,000
Debt covenant, exclusion of unrestricted cash and cash equivalents for ratio of consolidated funded indebtedness		$ 200,000,000
Debt covenant, maximum consolidated net leverage ratio		3
Debt covenant, minimum consolidated interest coverage ratio		3
Amount outstanding			$ 0
Minimum
Line of Credit Facility [Line Items]
Line of credit facility, unused capacity, commitment fee percentage		0.175%
Maximum
Line of Credit Facility [Line Items]
Line of credit facility, unused capacity, commitment fee percentage		0.275%
Secured Overnight Financing Rate (SOFR) | Revolving Credit Facility | Line of Credit
Line of Credit Facility [Line Items]
Basis spread on variable rate	0.10%
Secured Overnight Financing Rate (SOFR) | Minimum | Revolving Credit Facility | Line of Credit
Line of Credit Facility [Line Items]
Basis spread on variable rate	1%
Secured Overnight Financing Rate (SOFR) | Maximum | Revolving Credit Facility | Line of Credit
Line of Credit Facility [Line Items]
Basis spread on variable rate	1.75%
Variable Rate Component Two | Minimum | Revolving Credit Facility | Line of Credit
Line of Credit Facility [Line Items]
Basis spread on variable rate		0%
Variable Rate Component Two | Maximum | Revolving Credit Facility | Line of Credit
Line of Credit Facility [Line Items]
Basis spread on variable rate		0.75%

Revenues (Summary of Product Li

Revenues (Summary of Product Lines) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 28, 2024	Dec. 30, 2023	Dec. 28, 2024	Dec. 30, 2023
Disaggregation of Revenue [Line Items]
Net sales	$ 555,738	$ 618,984	$ 1,471,621	$ 1,417,063
Audio Products
Disaggregation of Revenue [Line Items]
Net sales	346,272	378,597	881,830	857,258
HPMS Products
Disaggregation of Revenue [Line Items]
Net sales	$ 209,466	$ 240,387	$ 589,791	$ 559,805

Revenues (Summary of Geographic

Revenues (Summary of Geographic Disaggregation) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 28, 2024	Dec. 30, 2023	Dec. 28, 2024	Dec. 30, 2023
Disaggregation of Revenue [Line Items]
Net sales	$ 555,738	$ 618,984	$ 1,471,621	$ 1,417,063
China
Disaggregation of Revenue [Line Items]
Net sales	373,449	429,240	904,899	899,168
United States
Disaggregation of Revenue [Line Items]
Net sales	5,638	9,115	13,325	16,157
Rest of World
Disaggregation of Revenue [Line Items]
Net sales	$ 176,651	$ 180,629	$ 553,397	$ 501,738

Restructuring Costs (Details)

Restructuring Costs (Details) - USD ($) $ in Thousands	3 Months Ended			9 Months Ended		12 Months Ended
	Dec. 28, 2024	Dec. 30, 2023	Sep. 23, 2023	Dec. 28, 2024	Dec. 30, 2023	Mar. 30, 2024
Restructuring Cost and Reserve [Line Items]
Restructuring costs	$ 0	$ (360)	$ 2,300	$ 0	$ 1,959
Recovery of restructuring cost		$ (400)
Employee Severance
Restructuring Cost and Reserve [Line Items]
Percentage of reduction in workforce						5%

Income Taxes (Provision for Inc

Income Taxes (Provision for Income Taxes) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 28, 2024	Dec. 30, 2023	Dec. 28, 2024	Dec. 30, 2023
Income Tax Disclosure [Abstract]
Income before income taxes	$ 153,701	$ 172,100	$ 350,309	$ 304,278
Provision for income taxes	$ 37,696	$ 33,377	$ 90,069	$ 74,548
Effective tax rate	24.50%	19.40%	25.70%	24.50%

Income Taxes (Narrative) (Detai

Income Taxes (Narrative) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 28, 2024	Dec. 30, 2023	Dec. 28, 2024	Dec. 30, 2023
Income Tax Disclosure [Abstract]
Income tax expense	$ 37,696	$ 33,377	$ 90,069	$ 74,548
Effective tax rate	24.50%	19.40%	25.70%	24.50%
Gross unrecognized tax benefits	$ 32,100		$ 32,100
Penalties and interest accrued	$ 11,300		11,300
Estimate of possible loss			168,300
Estimate of possible loss, penalties expense			$ 63,700

Net Income Per Share (Calculati

Net Income Per Share (Calculation of Basic and Diluted Earnings Per Share) (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 28, 2024	Dec. 30, 2023	Dec. 28, 2024	Dec. 30, 2023
Numerator:
Net income	$ 116,005	$ 138,723	$ 260,240	$ 229,730
Denominator:
Weighted average shares outstanding (in shares)	53,081	54,016	53,263	54,449
Effect of dilutive securities (in shares)	1,995	1,576	2,266	1,711
Weighted average diluted shares (in shares)	55,076	55,592	55,529	56,160
Basic earnings per share (in dollars per share)	$ 2.19	$ 2.57	$ 4.89	$ 4.22
Diluted earnings per share (in dollars per share)	$ 2.11	$ 2.50	$ 4.69	$ 4.09

Net Income Per Share (Narrative

Net Income Per Share (Narrative) (Details) - shares shares in Thousands	3 Months Ended		9 Months Ended
	Dec. 28, 2024	Dec. 30, 2023	Dec. 28, 2024	Dec. 30, 2023
Earnings Per Share [Abstract]
Weighted average shares outstanding excluded from diluted calculation (in shares)	228	388	224	394

Commitment and Contingencies (D

Commitment and Contingencies (Details) - USD ($) $ in Millions	Jul. 28, 2021	Dec. 28, 2024
Commitments and Contingencies Disclosure [Abstract]
Payments for capacity reservation fee	$ 60
Capacity reservation fee remaining		$ 20
Prepaid wafers	$ 195
Prepaid wafers balance		$ 89

Stockholders' Equity (Common St

Stockholders' Equity (Common Stock) (Details) - shares shares in Millions	3 Months Ended		9 Months Ended
	Dec. 28, 2024	Dec. 30, 2023	Dec. 28, 2024	Dec. 30, 2023
Stockholders' Equity Note [Abstract]
Common stock issued as part of stock incentive plan (in shares)	0.7	0.5	1	0.6

Stockholders' Equity (Share Rep

Stockholders' Equity (Share Repurchase Program) (Details) - USD ($) $ / shares in Units, $ in Thousands, shares in Millions	3 Months Ended		9 Months Ended		29 Months Ended
	Dec. 28, 2024	Dec. 30, 2023	Dec. 28, 2024	Dec. 30, 2023	Dec. 28, 2024	Jul. 31, 2022
Equity, Class of Treasury Stock [Line Items]
Accrued excise tax	$ 500		$ 500		$ 500
Common stock repurchased	70,026	$ 57,159	161,518	$ 136,934
July 2022 Repurchase Program
Equity, Class of Treasury Stock [Line Items]
Common stock approved under the share repurchase program						$ 500,000
Common stock repurchased	70,000		161,000		345,900
Common stock available for repurchase	$ 154,100		$ 154,100		$ 154,100
Common stock repurchased (in shares)	0.7		1.4
Average cost per share repurchased (in dollars per share)	$ 103.18		$ 115.31

Segment Information (Details)

Segment Information (Details)	9 Months Ended
	Dec. 28, 2024 segment product_line
Segment Reporting [Abstract]
Number of reportable segments | segment	1
Number of product lines | product_line	2